Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.83% |
| 2 | Healthcare | 3.13% |
| 3 | Technology | 2.97% |
| 4 | Financials | 2.19% |
| 5 | Consumer Discretionary | 2.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
10551
CALL
KRONOS Worldwide
KRO
$900M
| $183K | ﹤0.01% |
18,800
-11,500
| -38% | -$129K |
2020 Q2
18 quarters
|
|
10552
PUT
GraniteShares 2x Long AMZN Daily ETF
AMZZ
$46.7M
| $183K | ﹤0.01% |
5,300
+700
| +15% | +$21.6K |
2024 Q3
1 quarter
|
|
10553
PUT
Dr. Reddy's Laboratories
RDY
$10.2B
| $183K | ﹤0.01% |
11,600
-18,900
| -62% | -$284K |
2022 Q4
8 quarters
|
|
10554
PUT
Nurix Therapeutics
NRIX
$2.3B
| $183K | ﹤0.01% |
9,700
-700
| -7% | -$16K |
2022 Q4
8 quarters
|
|
|
PBPB
10555
CALL
DELISTED
Potbelly
PBPB
| $183K | ﹤0.01% |
19,400
+13,000
| +203% | +$118K |
2022 Q4
8 quarters
|
|
10556
PUT
DocGo
DCGO
$33.5M
| $183K | ﹤0.01% |
43,100
+40,100
| +1,337% | +$154K |
2022 Q3
9 quarters
|
|
|
LGF.B
10557
CALL
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $183K | ﹤0.01% |
24,200
+13,100
| +118% | +$91.8K |
2024 Q2
2 quarters
|
|
10558
CALL
iShares Micro-Cap ETF
IWC
$1.33B
| $183K | ﹤0.01% |
1,400
+900
| +180% | +$117K |
2024 Q3
1 quarter
|
|
|
CUK
10559
PUT
DELISTED
Carnival PLC
CUK
| $182K | ﹤0.01% |
8,100
-8,200
| -50% | -$174K |
2022 Q3
9 quarters
|
|
|
SRDX
10560
CALL
DELISTED
Surmodics
SRDX
| $182K | ﹤0.01% |
4,600
+3,200
| +229% | +$124K |
2022 Q4
8 quarters
|
|
10561
PUT
4D Molecular Therapeutics
FDMT
$702M
| $182K | ﹤0.01% |
32,700
-2,100
| -6% | -$16.5K |
2022 Q4
8 quarters
|
|
|
ARI
10562
PUT
Apollo Commercial Real Estate
ARI
$802M
| $182K | ﹤0.01% |
21,000
-1,600
| -7% | -$14.4K |
2020 Q1
19 quarters
|
|
10563
PUT
Core Laboratories
CLB
$466M
| $182K | ﹤0.01% |
10,500
-700
| -6% | -$13.5K |
2013 Q2
46 quarters
|
|
10564
CALL
iShares MSCI Malaysia ETF
EWM
$277M
| $182K | ﹤0.01% |
7,400
+6,100
| +469% | +$152K |
2024 Q3
1 quarter
|
|
10565
PUT
Koppers
KOP
$837M
| $181K | ﹤0.01% |
5,600
+3,800
| +211% | +$136K |
2022 Q4
8 quarters
|
|
10566
iShares MSCI Chile ETF
ECH
$961M
| $181K | ﹤0.01% |
7,243
-23,609
| -77% | -$609K |
2024 Q3
1 quarter
|
|
10567
StealthGas
GASS
$347M
| $181K | ﹤0.01% |
32,100
+28,384
| +764% | +$166K |
2024 Q2
2 quarters
|
|
10568
CALL
Napco Security Technologies
NSSC
$1.26B
| $181K | ﹤0.01% |
5,100
-33,700
| -87% | -$1.29M |
2022 Q4
8 quarters
|
|
10569
PUT
RLI Corp
RLI
$5.17B
| $181K | ﹤0.01% |
2,200
-6,800
| -76% | -$565K |
2024 Q2
2 quarters
|
|
10570
CALL
ICL Group
ICL
$6.45B
| $181K | ﹤0.01% |
36,700
+14,500
| +65% | +$64.8K |
2021 Q4
12 quarters
|
|
10571
Schwab US Mid-Cap ETF
SCHM
$14.5B
| $181K | ﹤0.01% |
6,539
-47,431
| -88% | -$1.35M |
2022 Q3
9 quarters
|
|
10572
CALL
State Street DoubleLine Total Return Tactical ETF
TOTL
$3.67B
| $181K | ﹤0.01% |
+4,600
| New | +$185K |
2024 Q4
0 quarters
|
|
|
TGI
10573
PUT
DELISTED
Triumph Group
TGI
| $181K | ﹤0.01% |
9,700
+8,300
| +593% | +$138K |
2020 Q1
19 quarters
|
|
10574
Liberty Media Corporation Series C Common Stock
FWONK
$23.8B
| $181K | ﹤0.01% |
1,953
-11,107
| -85% | -$943K |
2023 Q1
7 quarters
|
|
10575
CALL
Gaotu Techedu
GOTU
$637M
| $181K | ﹤0.01% |
82,500
-77,500
| -48% | -$226K |
2019 Q4
20 quarters
|
|
Similar funds
Citadel Advisors's Q4 2024 Portfolio in Review
As of Q4 2024, Citadel Advisors held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors's Q4 2024 filing shows 1,745 new, 6,427 increased, 6,082 reduced and 1,421 closed positions. Its largest new stake was Zoetis: 1,090,499 shares worth $178M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, down from 83% a quarter earlier, followed by Healthcare and Technology.
- Citadel Advisors's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Citadel Advisors added most to Boeing in Q4 2024, an estimated $830M increase.
- Citadel Advisors's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Citadel Advisors fully exited Spotify in Q4 2024, selling an estimated $473M.
- Citadel Advisors's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Citadel Advisors opened 1,745 new positions and closed 1,421 in Q4 2024.
- Citadel Advisors's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.